<p>We profiled the miRNA contents from cerebrospinal fluid and serum (using next generation sequencing) from postmortem patients diagnosed with Alzheimer's or Parkinson's disease, and neurologically normal controls. All biofluids were cell-free and patient matched, there was one cerebrospinal fluid and one serum sample from each of 70 patients with Alzheimer's disease, 67 patients with Parkinson's disease and 78 age-similar controls. We correlated the miRNA changes with measurements of neuropathology such as plaques, tangles and Lewy bodies.</p>

miRNA Profiles in Serum and CSF of Parkinson's and Alzheimer's Patients

Alzheimer Disease study with miRNA-Seq data on dbGaP (211 participants)

miRNA Profiles in Serum and CSF of Parkinson's and Alzheimer's Patients

Description

Applying For Access

Summary